AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 286: E896-E901, 2004. First published January 13, 2004; doi:10.1152/ajpendo.00327.2003
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/E896    most recent
00327.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chisalita, S. I.
Right arrow Articles by Arnqvist, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chisalita, S. I.
Right arrow Articles by Arnqvist, H. J.

Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells

Simona I. Chisalita1 and Hans J. Arnqvist1,2

1Division of Cell Biology, Department of Biomedicine and Surgery, and 2Division of Internal Medicine, Department of Medicine and Care, Faculty of Health Sciences, Linköping University, S-581 85 Linkoping, Sweden

Submitted 15 July 2003 ; accepted in final form 5 January 2004

Micro- and macroangiopathy are major causes of morbidity and mortality in patients with diabetes. Our aim was to characterize IGF-I receptor (IGF-IR) and insulin receptor (IR) in human micro- and macrovascular endothelial cells. Cultured human dermal microvascular endothelial cells (HMVEC) and human aortic endothelial cells (HAEC) were used. Gene expression was measured by quantitative real-time RT-PCR and receptor protein by ligand-binding assay. Phosphorylation of IGF-IR {beta}-subunit was analyzed by immunoprecipitation and Western blot. Glucose metabolism and DNA synthesis was assessed using [3H]glucose and [3H]thymidine incorporation, respectively. We detected gene expression of IGF-IR and IR in HAEC and HMVEC. IGF-IR gene expression was severalfold higher than that of IR. The specific binding of 125I-IGF-I was higher than that of 125I-insulin in HAEC and HMVEC. Insulin and the new, long-acting insulin analog glargine interacted with the IGF-IR with thousand- and hundred-fold less potency than IGF-I itself. Phosphorylation of the IGF-IR {beta}-subunit was shown in HAEC for IGF-I (10–8 M) and insulin (10–6 M) and in HMVEC for IGF-I and glargine (10–8 M, 10–6 M). IGF-I 10–7 M stimulated incorporation of [3H]thymidine into DNA, and 10–9–10–7 M also the incorporation of [3H]glucose in HMVEC, whereas glargine and insulin had no significant effects at 10–9–10–7 M. Human micro- and macrovascular endothelial cells express more IGF-IR than IR. IGF-I and high concentrations of glargine and insulin activates the IGF-IR. Glargine has a higher affinity than insulin for the IGF-IR but probably has no effect on DNA synthesis at concentrations reached in vivo.

human endothelial cells; receptor; insulin; glargine



Address for reprint requests and other correspondence: H. Arnqvist, Dept. of Biomedicine and Surgery, Division of Cell Biology, Univ. Hospital, S-581 85 Linkoping, Sweden (E-mail: hans.arnqvist{at}ibk.liu.se).




This article has been cited by other articles:


Home page
DiabetesHome page
H. Wang, A. X. Wang, Z. Liu, and E. J. Barrett
Insulin Signaling Stimulates Insulin Transport by Bovine Aortic Endothelial Cells
Diabetes, March 1, 2008; 57(3): 540 - 547.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. A. Marini, E. Succurro, S. Frontoni, M. L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, and G. Sesti
Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women
Diabetes Care, August 1, 2007; 30(8): 2145 - 2147.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Wang, G. Chakravarty, S. Kim, Y. D. Yazici, M. N. Younes, S. A. Jasser, A. A. Santillan, C. D. Bucana, A. K. El-Naggar, and J. N. Myers
Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma
Clin. Cancer Res., August 1, 2006; 12(15): 4755 - 4765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Wang, Z. Liu, G. Li, and E. J. Barrett
The vascular endothelial cell mediates insulin transport into skeletal muscle
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E323 - E332.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. van Golen, T. S. Schwab, B. Kim, M. E. Soules, S. Su Oh, K. Fung, K. L. van Golen, and E. L. Feldman
Insulin-Like Growth Factor-I Receptor Expression Regulates Neuroblastoma Metastasis to Bone.
Cancer Res., July 1, 2006; 66(13): 6570 - 6578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. R. Gosmanov, F. B. Stentz, and A. E. Kitabchi
De novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E516 - E522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.